Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: povidone; mannitol; purified water; meglumine; sodium hydroxide; lactose monohydrate; sodium stearylfumarate; magnesium stearate; iron oxide red - telmisartan hct gh is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: magnesium stearate; mannitol; sodium hydroxide; povidone; polysorbate 80; meglumine; purified water - 1) treatment of hypertension,2) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; magnesium stearate; mannitol; povidone; meglumine - telmisartan mylan is indicated for:,? treatment of hypertension,? prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: sodium stearylfumarate; magnesium stearate; mannitol; meglumine; sodium hydroxide; povidone - apo-telmisartan is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan apel is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan alsa is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan ch is indicated for:- treatment of hypertension - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan ap is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan agl is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan alem is indicated for:,? treatment of hypertension in adults,? prevention of cardiovascular morbidity and mortality in adults 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see section 5.1 pharmacodynamic properties, clinical trials)